One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 380,000 shares of Pfizer Inc. (NYSE: PFE) on Wednesday, as the price of this fund was up over 1% in the day’s session. It is also up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 382,231 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $17.6 million. This is only a small fraction of the total holdings. The fund is up about 42% over the past 52 weeks.
Check out all the ARK Invest buys for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | TDOC | TELADOC HEALTH | 16,089 |
| ARKF | Z | ZILLOW | 2,688 |
| ARKG | RPTX | REPARE THERAPEUTICS | 3,200 |
| ARKG | PSNL | PERSONALIS | 3,781 |
| ARKG | PFE | PFIZER | 382,231 |
| ARKG | NVTA | INVITAE | 12,514 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 800 |
| ARKK | FATE | FATE THERAPEUTICS | 1,075 |
| ARKK | SGFY | SIGNIFY HEALTH | 189,960 |
| ARKQ | ACIC | ATLAS CREST INVESTMENT | 144,000 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 36,482 |
| ARKQ | SPFR | JAWS SPITFIRE ACQUISITION | 14,879 |
| ARKQ | KMTUY | KOMATSU | 103,400 |
| ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 41,408 |
| ARKQ | MKFG | MARKFORGED | 56,216 |
| ARKW | GENI | GENIUS SPORTS | 121,401 |
| ARKX | 6301JP | KOMATSU | 62,800 |
| ARKX | ACIC | ATLAS CREST INVESTMENT | 31,000 |
| ARKX | PRNT | 3D PRINTING ETF | 8,903 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
